Patents Assigned to ChiRhoClin, Inc.
  • Methods for treatment of COVID-19 syndrome
    Patent number: 11744878
    Abstract: The invention relates generally to methods for treating and modulating the severity of COVID-19 syndrome. The methods comprise administering a therapeutically effective amount of a pharmaceutical composition to a human patient, the composition comprising secretin and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: September 5, 2023
    Assignee: CHIRHOCLIN, INC.
    Inventor: Edward D. Purich
  • Methods of detecting pancreobiliary ductal leaks
    Patent number: 11406718
    Abstract: The present invention is directed to a method for identifying ductal leaks during pancreobiliary surgery in a human patient. The invention comprises the steps of: administering to a human patient undergoing pancreobiliary surgery an effective amount of a pharmaceutical composition comprising secretin and a pharmaceutically acceptable carrier; and observing the patient during the surgery for the presence of pancreobiliary ductal leaks.
    Type: Grant
    Filed: May 14, 2013
    Date of Patent: August 9, 2022
    Assignee: CHIRHOCLIN, INC.
    Inventor: Edward E. Purich
  • Methods for treating pain associated with chronic pancreatitis
    Patent number: 9962430
    Abstract: The invention relates generally to methods for treating pain associated with chronic pancreatitis in patients. The methods comprise administering a therapeutically effective amount of a pharmaceutical composition comprising secretin and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: February 13, 2013
    Date of Patent: May 8, 2018
    Assignee: CHIRHOCLIN, INC.
    Inventor: Edward D. Purich
  • Methods for treatment of acute pancreatitis
    Patent number: 7381698
    Abstract: The invention relates generally to methods for treating acute pancreatitis in patients. The methods comprise administering a therapeutically effective amount of a pharmaceutical composition comprising secretin and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: December 8, 2004
    Date of Patent: June 3, 2008
    Assignee: ChiRhoClin, Inc.
    Inventors: Seymour H. Fein, Edward D. Purich